We are excited to announce a brand new educational opportunity for brain cancer patients and caregivers! The Brains Matter Webinar Series which will be a monthly program offering educational and support information on the newest treatment available for your brain cancer or brain tumor. The webinars will also offer care resources and education in helping the ones you love with a brain tumor or brain cancer. Below is details on this month’s first webinar:
Brains Matter Webinar Series: “Top 10 Vital Questions You Must Ask Your Doctor IMMEDIATELY When Diagnosed with a Brain Tumor”
When: January 17th 2013 at 11:00am to 12:00pm PST
Where: Your computer or phone, sign up to virtually attend this webinar
Who: Dr. Greg Foltz, Neurosurgeon and Director of the Ivy Brain Tumor Center at the Swedish Neuroscience Institute of Seattle, WA
Dellann Elliott, Founder and President, Chris Elliott Fund
Maria Barrett, Health Information Concierge , Chris Elliott Fund
What: The rush to learn as much vitally important information once diagnosed with a brain tumor is easily overwhelming. We’d like to help simplify and demystify this process by sharing the 10 most important questions to ask your neurosurgeon or neuro-oncologist once diagnosed with a brain tumor.
The first of our series of webinars for brain tumor patients and caregivers will touch on important things you may or may not know about brain cancer/brain tumor treatment and help direct the focus of your conversation with your doctor to make sure you have the right information before executing your treatment plan.
Questions? Sign up for the webinar today and you’ll get the chance to ask our panel of experts personally!
Register Today: https://attendee.gotowebinar.com/register/525847281019240192
As always feel free to reach out to the Chris Elliott Fund for patient and caregiver support at firstname.lastname@example.org
Stay tuned to the Chris Elliott Fund blog, website and Facebook page as we will be announcing several webinars throughout the year, including nutritional information, and pediatric brain tumor information.
The Chris Elliott Fund is able to offer these vital services to brain cancer and brain tumor patients through the generous support from Genentech, a biotechnology company based in San Francisco, and member of the Roche Group.